Genprex
GNPX
15 hedge funds and large institutions have $165K invested in Genprex in 2026 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 4 closing their positions.
1,170% more capital invested
Capital invested by funds: $13K → $165K (+$152K)
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
67% more funds holding
Funds holding: 9 → 15 (+6)
0.12% more ownership
Funds ownership: 0.01% → 0.14% (+0.12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$72.2K |
| 2 |
MF
Manchester Financial
Westlake Village,
California
|
+$43.3K |
| 3 |
MFA
Mayflower Financial Advisors
Boston,
Massachusetts
|
+$43.3K |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$10.8K |
| 5 |
CCA
Cygnus Capital Advisors
Atlanta,
Georgia
|
+$4.76K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.74K |
| 2 |
MWA
Miller Wealth Advisors
Ridgeway,
Colorado
|
-$2.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$190 |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$31 |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$5 |
GNPX Hedge Fund Activity: Q1 2026 in Review
15 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q1 2026, worth a combined $165K — up 1,170% from $13K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new GNPX positions and 4 closed out — a net gain of 6 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $72.2K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $5.74K sold.
- 15 institutional investors held Genprex (GNPX) as of Q1 2026, up from 9 in Q4 2025.
- Funds reported $165K of Genprex stock for Q1 2026, up 1,170% quarter-over-quarter.
- 10 funds opened new Genprex positions in Q1 2026 and 4 closed out, a net change of +6 holders.
- The largest Genprex buyer in Q1 2026 was Geode Capital Management, an estimated $72.2K added.
- The largest Genprex seller in Q1 2026 was Tower Research Capital (TRC), an estimated $5.74K sold.
Based on aggregated 13F filings for Q1 2026.